Neurotech
Lincoln, Rhode Island, United States
About Neurotech
Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseases–including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $49.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2006)
- Website: neurotechpharmaceuticals.com
- Phone: 401-333-3880
Industries & Categories
Biotechnology, Health Care, Hospital, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/neurotech-2247357 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.